FFA
GSK icon

Fairfield Financial Advisors’s GSK GSK Stock Holding History

Fairfield Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-345
Closed -$12.3K – 306
2023
Q2 		$12.3K Hold
345
– – ﹤0.01% 224
2023
Q1 		$12.2K Hold
345
– – 0.01% 229
2022
Q4 		$12.1K Hold
345
– – 0.01% 205
2022
Q3 		$10.2K Buy
345
+3
+0.9% +$114 ﹤0.01% 211
2022
Q2 		$18.6K Buy
342
+4
+1% +$221 0.01% 163
2022
Q1 		$18.4K Buy
+338
New +$18.4K 0.01% 184

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fairfield Financial Advisors's GSK Position: Q3 2023 in Review

Fairfield Financial Advisors sold out of GSK (GSK) in Q3 2023, closing a stake of 345 shares — an estimated $12.3K sold.

Fairfield Financial Advisors first reported a position in GSK in Q1 2022 and held it in 6 quarters. The position peaked at $18.6K in Q2 2022. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

  • Fairfield Financial Advisors reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
  • Fairfield Financial Advisors sold 345 GSK shares in Q3 2023, an estimated $12.3K.
  • Fairfield Financial Advisors first reported a position in GSK in Q1 2022 and held it in 6 quarters.
  • Fairfield Financial Advisors's GSK position peaked at $18.6K in Q2 2022.
  • 846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Fairfield Financial Advisors's 13F filing for Q3 2023, filed 4 Nov 2024.